Clinical Trial Update: A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating Avastin (bevacizumab) in patients previously treated in a Genentech-sponsored cancer study; the study included breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Breast Cancer, Colorectal Cancer | Phase 3 | Status: COMPLETED